NO20012464L - 13-leddete azalider og deres anvendelse som antibiotiske midler - Google Patents

13-leddete azalider og deres anvendelse som antibiotiske midler

Info

Publication number
NO20012464L
NO20012464L NO20012464A NO20012464A NO20012464L NO 20012464 L NO20012464 L NO 20012464L NO 20012464 A NO20012464 A NO 20012464A NO 20012464 A NO20012464 A NO 20012464A NO 20012464 L NO20012464 L NO 20012464L
Authority
NO
Norway
Prior art keywords
antibiotics
membered azalides
azalides
membered
Prior art date
Application number
NO20012464A
Other languages
English (en)
Other versions
NO20012464D0 (no
NO319796B1 (no
Inventor
Robert John Rafka
Barry James Morton
Colman Brendan Ragan
Peter Bertinato
John Philip Dirlam
Alan Elwood Blize
Carl Bernard Ziegler
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22327457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012464(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20012464D0 publication Critical patent/NO20012464D0/no
Publication of NO20012464L publication Critical patent/NO20012464L/no
Publication of NO319796B1 publication Critical patent/NO319796B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20012464A 1998-11-20 1999-11-09 13-leddete azalider, fremgangsmåte for fremstilling og anvendelse derav samt farmasøytisk sammensetning. NO319796B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10939998P 1998-11-20 1998-11-20
PCT/IB1999/001803 WO2000031097A1 (en) 1998-11-20 1999-11-09 13-membered azalides and their use as antibiotic agents

Publications (3)

Publication Number Publication Date
NO20012464D0 NO20012464D0 (no) 2001-05-18
NO20012464L true NO20012464L (no) 2001-07-17
NO319796B1 NO319796B1 (no) 2005-09-19

Family

ID=22327457

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20012464A NO319796B1 (no) 1998-11-20 1999-11-09 13-leddete azalider, fremgangsmåte for fremstilling og anvendelse derav samt farmasøytisk sammensetning.
NO20050893A NO330249B1 (no) 1998-11-20 2005-02-18 Azalider samt anvendelser og fremstilling derav, og farmasøytiske sammensetninger
NO20050904A NO329629B1 (no) 1998-11-20 2005-02-18 13-leddete azalider

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20050893A NO330249B1 (no) 1998-11-20 2005-02-18 Azalider samt anvendelser og fremstilling derav, og farmasøytiske sammensetninger
NO20050904A NO329629B1 (no) 1998-11-20 2005-02-18 13-leddete azalider

Country Status (46)

Country Link
US (1) US6329345B1 (no)
EP (1) EP1131331B1 (no)
JP (1) JP3842973B2 (no)
KR (1) KR100477774B1 (no)
CN (2) CN101367853A (no)
AP (1) AP2001002142A0 (no)
AR (3) AR019496A1 (no)
AT (1) ATE260927T1 (no)
AU (1) AU766106B2 (no)
BG (1) BG65107B1 (no)
BR (2) BRPI9915480B8 (no)
CA (1) CA2351429C (no)
CO (1) CO5380019A1 (no)
CZ (1) CZ303099B6 (no)
DE (1) DE69915336T2 (no)
DK (1) DK1131331T3 (no)
DZ (1) DZ2944A1 (no)
EA (2) EA009729B1 (no)
EG (1) EG23823A (no)
ES (1) ES2216581T3 (no)
GT (1) GT199900198A (no)
HK (1) HK1041269A1 (no)
HR (1) HRP20010374B1 (no)
HU (1) HU229008B1 (no)
ID (1) ID28548A (no)
IL (3) IL142631A0 (no)
IS (1) IS2350B (no)
MA (1) MA26707A1 (no)
ME (1) ME00467B (no)
MY (1) MY122353A (no)
NO (3) NO319796B1 (no)
NZ (1) NZ511199A (no)
OA (1) OA11713A (no)
PA (1) PA8485601A1 (no)
PE (1) PE20001378A1 (no)
PL (1) PL198580B1 (no)
PT (1) PT1131331E (no)
RS (1) RS50302B (no)
SI (1) SI1131331T1 (no)
SK (1) SK284607B6 (no)
TN (1) TNSN99214A1 (no)
TW (2) TWI243825B (no)
UA (1) UA70972C2 (no)
UY (1) UY25805A1 (no)
WO (1) WO2000031097A1 (no)
ZA (1) ZA200104019B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
CN1351608A (zh) * 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
MXPA03009786A (es) * 2001-04-27 2004-01-29 Pfizer Prod Inc Procedimiento para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-sustituidos.
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
MXPA06005639A (es) * 2003-11-21 2006-08-17 Pfizer Prod Inc Adyuvante antimicrobiano.
EP1985620A4 (en) * 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd COMPOUND 10a-AZALIDE
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
WO2012038372A1 (en) * 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
WO2015014907A1 (en) * 2013-07-31 2015-02-05 Farma Grs, D.O.O. Process for preparation of tulathromycin
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
SG11202105228SA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C11-cyclic substituted 13-membered macrolides and uses thereof
CN113573779A (zh) * 2018-11-19 2021-10-29 齐卡尼治疗股份有限公司 C10-亚烷基取代的13元大环内酯及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
GB2327084A (en) * 1997-07-08 1999-01-13 Merck & Co Inc 9a-Aza-3-ketolide antibiotics
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
NO20012464D0 (no) 2001-05-18
EP1131331A1 (en) 2001-09-12
NO20050904L (no) 2001-07-17
CZ20011754A3 (cs) 2002-03-13
EG23823A (en) 2007-09-19
BRPI9915480B1 (pt) 2015-12-29
NO319796B1 (no) 2005-09-19
SK6632001A3 (en) 2002-07-02
EA200400701A1 (ru) 2004-12-30
DE69915336D1 (de) 2004-04-08
US6329345B1 (en) 2001-12-11
HUP0104313A2 (hu) 2002-02-28
YU33401A (sh) 2004-05-12
AR059523A2 (es) 2008-04-09
KR100477774B1 (ko) 2005-03-21
RS50302B (sr) 2009-09-08
KR20010086043A (ko) 2001-09-07
IS5918A (is) 2001-04-17
EP1131331B1 (en) 2004-03-03
HRP20010374A2 (en) 2002-06-30
SI1131331T1 (en) 2004-08-31
NZ511199A (en) 2003-08-29
MA26707A1 (fr) 2004-12-20
ATE260927T1 (de) 2004-03-15
AU1068600A (en) 2000-06-13
TWI243825B (en) 2005-11-21
UA70972C2 (uk) 2004-11-15
ES2216581T3 (es) 2004-10-16
DZ2944A1 (fr) 2004-03-15
HRP20010374B1 (en) 2006-09-30
AR019496A1 (es) 2002-02-20
PE20001378A1 (es) 2000-12-14
IL189430A (en) 2010-05-31
TWI243824B (en) 2005-11-21
ID28548A (id) 2001-05-31
CZ303099B6 (cs) 2012-04-04
AR059524A2 (es) 2008-04-09
AU766106B2 (en) 2003-10-09
BG105600A (en) 2001-12-29
MY122353A (en) 2006-04-29
JP2002530422A (ja) 2002-09-17
ME00467B (me) 2011-10-10
CA2351429A1 (en) 2000-06-02
CA2351429C (en) 2005-07-12
JP3842973B2 (ja) 2006-11-08
EA005156B1 (ru) 2004-12-30
DK1131331T3 (da) 2004-06-14
ZA200104019B (en) 2002-06-17
BRPI9915480B8 (pt) 2022-05-10
PL198580B1 (pl) 2008-06-30
SK284607B6 (sk) 2005-07-01
NO20050893L (no) 2001-07-17
CN101367853A (zh) 2009-02-18
AP2001002142A0 (en) 2001-05-09
IL142631A (en) 2010-05-31
TW200404077A (en) 2004-03-16
PT1131331E (pt) 2004-06-30
TNSN99214A1 (fr) 2005-11-10
HUP0104313A3 (en) 2003-12-29
IS2350B (is) 2008-04-15
CN1326460A (zh) 2001-12-12
CO5380019A1 (es) 2004-03-31
HK1041269A1 (zh) 2002-07-05
PL347784A1 (en) 2002-04-22
UY25805A1 (es) 2001-08-27
PA8485601A1 (es) 2000-09-29
DE69915336T2 (de) 2005-01-13
NO330249B1 (no) 2011-03-14
EA009729B1 (ru) 2008-02-28
WO2000031097A1 (en) 2000-06-02
BG65107B1 (bg) 2007-02-28
GT199900198A (es) 2001-05-11
NO329629B1 (no) 2010-11-22
EA200100416A1 (ru) 2001-10-22
OA11713A (en) 2005-01-25
IL142631A0 (en) 2002-03-10
BR9915480A (pt) 2001-07-31
HU229008B1 (en) 2013-07-29
IL189430A0 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
NO20050893L (no) 13-leddete azalider og deres anvendelse som antibiotiske midler
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20020683D0 (no) Arylmetylkarbonylaminotiazolderivater og deres anvendelse som antitumormidler
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
DK1198454T3 (da) Multilinderivater og deres anvendelse som antibakterielle midler
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
DE69913738D1 (de) Ketolid-antibiotika
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20014702L (no) Diarylderivater og deres anvendelse som medikamenter
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
IS5919A (is) Ný makrólíð sýklalyf
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO994510D0 (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
NO20010250L (no) Nocatiacin-antibiotika
NO995513D0 (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-A agonister
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
NO20004904L (no) C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter
ATE269074T1 (de) Doramectinformulierungen
DK1367055T3 (da) Isoquinolinylcarboxamider og deres anvendelse som krampestillende midler
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse
DK1072266T3 (da) Thienylazolylalkoxyethanaminer, deres fremstilling og deres anvendelse som lægemidler

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US

MK1K Patent expired